ARKG
ARK Genomic Revolution ETF

Price: $33.66
Change: $2.59 (0.08%)
Category: Health & Biotech Equities
Last Updated:

Vitals

Issuer ARK
Brand ARK
Structure ETF
Expense Ratio 0.75%
ETF Home Page Home page
Inception Oct 31, 2014
Index Tracked ACTIVE - No Index

Analyst Report

The ARK Genomic Revolution ETF (ARKG) is an actively-managed fund from the team at ARK Invest that tries to pick the companies best positioned to profit from advancements in energy, automation, manufacturing, materials and transportation.


The advisory firm, led by Catherine Wood, has an impressive track record doing what most stock pickers fail to do: beating the market.


ARKG invests in companies that could profit from technological and scientific advancements in gene editing, genetic therapy, molecular diagnostics, and stem cell advances.


It’s a niche product without a lot of competition. ARKG’s nearest rival is likely the iShare Genomics immunology and Healthcare ETF, an index-tracking ETF that launched in June 2019.


Beyond the active/passive difference, IDNA’s holdings are dominated by major pharmaceutical firms like Moderna, Regeneron and Gilead Sciences, whereas ARKG’s portfolio is tilted toward significantly smaller firms.


There isn’t a lot of performance history to compare, but it’s worth nothing that IDNA beat ARKG in the first ten weeks of 2020, when global markets were rocked by the coronavirus outbreak and investors were eagerly hunting for potential profit in companies researching treatment and vaccines.


But that’s just a fleeting snapshot during a particularly turbulent time. Any actively-managed product is ultimately a bet on the portfolio managers who pick the stocks. ARK’s products are geared toward investors who have the fortitude and faith to ride out short-term blips in favor of the prospect long-term alpha.

ETF Database Themes

Category Health & Biotech Equities
Asset Class Equity
Asset Class Size Multi-Cap
Asset Class Style Growth
Sector (General) Healthcare
Sector (Specific) Biotechnology
Region (General) North America
Region (Specific) U.S.

FactSet Classifications

Segment Equity: Global Genomic Advancements
Category Sector
Focus Theme
Niche Genomic Advancements
Strategy Active
Weighting Scheme Proprietary

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $26.38
  • 52 Week Hi $93.55
  • AUM $2,363.1 M
  • Shares 76.1 M

Historical Trading Data

  • 1 Month Avg. Volume 3,613,218
  • 3 Month Avg. Volume 4,031,259

Alternative ETFs in the ETF Database Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $2.7 B 189,255 -11.51%
Largest (AUM) XLV 0.10% $36.6 B 13 M -9.13%
Most Liquid (Volume) XBI 0.35% $6.6 B 15 M -31.91%
Top YTD Performer PPH 0.35% $505.1 M 175,491 -0.59%

Alternative ETFs in the FactSet Equity: Global Genomic Advancements Segment

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest IDNA 0.47% $178.3 M 49,352 -32.53%
Largest (AUM) IDNA 0.47% $178.3 M 49,352 -32.53%
Most Liquid (Volume) GNOM 0.50% $169.3 M 169,283 -36.57%
Top YTD Performer IDNA 0.47% $178.3 M 49,352 -32.53%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to its peers.

Holdings Comparison

ARKG ETF Database Category Average FactSet Segment Average
Number of Holdings 49 103 46
% of Assets in Top 10 47.31% 41.32% 44.64%
% of Assets in Top 15 63.17% 53.90% 60.71%
% of Assets in Top 50 99.99% 88.71% 99.99%

Size Comparison

ARKG ETF Database Category Average FactSet Segment Average
Large (>12.9B) 11.19% 55.77% 40.93%
Mid (>2.7B) 42.85% 22.89% 33.41%
Small (>600M) 32.55% 16.78% 19.92%
Micro (<600M) 13.42% 4.56% 5.74%

ARKG Valuation

This section compares the P/E ratio of this ETF to its peers.

ARKG
P/E Ratio
N/A
ETF Database Category Average
P/E Ratio
22.99
FactSet Segment Average
P/E Ratio
0.45

ARKG Dividend

This section compares the dividend yield of this ETF to its peers.

ARKG ETF Database Category Average FactSet Segment Average
Dividend $ 0.79 $ 0.19 $ 0.23
Dividend Date 2020-12-29 N/A N/A
Annual Dividend Rate $ 0.79 $ 0.51 $ 0.24
Annual Dividend Yield 1.07% 0.51% 0.38%

ARKG Price and Volume Charts

View charts featuring ARKG price and volume data.

ARKG Fund Flows Charts

View charts featuring ETF fund flow data.

5 Day Net Flows: -49.82 M 1 Month Net Flows: -106.41 M 3 Month Net Flows: -125.02 M 6 Month Net Flows: -411.26 M 1 Year Net Flows: -1.59 B 3 Year Net Flows: 6.22 B 5 Year Net Flows: 6.59 B 10 Year Net Flows: 6.6 B

ARKG Price vs Flows AUM Influence Charts

View charts that break down the influence that fund flows and price had on overall assets.

5 Day Net AUM Change: 110.39 M
1 Month Net AUM Change: -117.53 M
3 Month Net AUM Change: -1.29 B
6 Month Net AUM Change: -3.03 B
1 Year Net AUM Change: -6.49 B
3 Year Net AUM Change: 1.94 B
5 Year Net AUM Change: 2.35 B
10 Year Net AUM Change: 2.36 B

Realtime Rating

The adjacent table gives investors an individual Realtime Rating for ARKG on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETF Database Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETF Database Pro. To view information on how the ETF Database Realtime Ratings work, click here.

Sign Up for Pro to Unlock Data Sign Up
Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity n/a n/a
Expenses C n/a
Performance
Volatility
Dividend
Concentration

A+ Overall Rated ETF:

ARKG Expenses & Fees

This section compares the cost efficiency of this ETF to its peers.

Expenses Ratio Analysis

ARKG
Expense Ratio
0.75%
ETF Database Category Average
Expense Ratio
0.49%
FactSet Segment Average
Expense Ratio
0.56%

Tax Analysis

Max ST Capital Gains Rate 39.60%
Max LT Capital Gains Rate 20.00%
Tax On Distributions Qualified dividends
Distributes K1 No
ESG Themes and Scores
5.62/10
ESG Score
29.86%
Global Percentile
23.49%
Peer Percentile
Environmental
Social
Governance
  • Environmental Scores
    • Revenue Exposure to Environmental Impact (%)
      Higher is better, no ESG score impact
    • Severe Environment Controversies (%)
      Lower improves ESG score
    • Sustainable Impact Solutions (%)
      12.75%
      Higher is better, no ESG score impact
    Carbon Intensity
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      21.24
      Higher is worse, no ESG score impact
    Fossil Fuel Reserves
    • Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • High Impact Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    Water Stress
    • Water Stress High Risk Business Segment (%)
      Lower improves ESG score
    • Water Stress High Risk Geography (%)
      Lower improves ESG score
    • Water Stress Exposure Moderate (%)
      Lower improves ESG score
    • Water Stress Exposure High (%)
      Lower improves ESG score
    • Water Stress Exposure Low (%)
      Higher improves ESG score
    Energy Efficiency
    • Revenue Exposure to Energy Efficiency (%)
      Higher is better, no ESG score impact
    Alternative Energy
    • Revenue Exposure to Alternative Energy (%)
      Higher is better, no ESG score impact
    Green Building
    • Revenue Exposure to Green Building (%)
      Higher is better, no ESG score impact
    Pollution Prevention
    • Revenue Exposure to Pollution Prevention (%)
      Higher is better, no ESG score impact
    Water Sustainability
    • Revenue Exposure to Water Sustainability (%)
      Higher is better, no ESG score impact
  • Social Scores
    • Revenue Exposure to Social Impact (%)
      Higher is better, no ESG score impact
    • Sustainable Impact Solutions (%)
      12.75%
      Higher is better, no ESG score impact
    • SRI Exclusion Criteria (%)
      0.0%
      Higher is worse, no ESG score impact
    Affordable Real Estate
    • Revenue Exposure to Affordable Real Estate (%)
      Higher is better, no ESG score impact
    Education
    • Revenue Exposure to Education (%)
      Higher is better, no ESG score impact
    Major Disease Treatment
    • Revenue Exposure to Major Disease Treatment (%)
      Higher is better, no ESG score impact
    Healthy Nutrition
    • Revenue Exposure to Nutrition (%)
      Higher is better, no ESG score impact
    Global Sanitation
    • Revenue Exposure to Sanitation (%)
      Higher is better, no ESG score impact
    SME Finance
    • Revenue Exposure to SME Finance (%)
      Higher is better, no ESG score impact
    Human Rights Violations
    • Human Rights Norms Violation (%)
      Higher is worse, no ESG score impact
    • Human Rights Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Human Rights Controversies (%)
      Lower improves ESG score
    Labor Rights Violations
    • Labor Norms Violation (%)
      Higher is worse, no ESG score impact
    • Labor Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Labor Controversies (%)
      Lower improves ESG score
    Customer Controversies
    • Severe Customer Controversies (%)
      Lower improves ESG score
    UN Principles Violations
    • Global Compact Compliance Violation (%)
      Higher is worse, no ESG score impact
    • Global Compact Compliance Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    Catholic Values
    • Catholic Values Fail (%)
      Higher is worse, no ESG score impact
    Sharia Compliant Investing
    • Islamic Non-Compliant (%)
      Higher is worse, no ESG score impact
    Adult Entertainment
    • Adult Entertainment Involvement (%)
      Higher is worse, no ESG score impact
    Alcohol
    • Alcohol Involvement (%)
      Higher is worse, no ESG score impact
    Gambling
    • Gambling Involvement (%)
      Higher is worse, no ESG score impact
    Nuclear Power
    • Nuclear Power Involvement (%)
      Higher is worse, no ESG score impact
    Tobacco
    • Tobacco Involvement (%)
      Higher is worse, no ESG score impact
    Weapons Involvement
    • Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Controversies Weapons Involvement (%)
      Higher is worse, no ESG score impact
    Firearms
    • Civilian Firearms Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Retailer (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Producer (%)
      Higher is worse, no ESG score impact
    Predatory Lending
    • Direct Predatory Lending Involvement (%)
      Higher is worse, no ESG score impact
    GMO Involvement
    • Genetic Engineering Involvement (%)
      Higher is worse, no ESG score impact
  • Responsible Governance Score
    • Severe Governance Controversies (%)
      Lower improves ESG score
    Board Flag
    • Board Flag (%)
      Lower improves ESG score
    Board Independence
    • Lack of Independent Board Majority (%)
      Lower improves ESG score
    • Board Independence (0-25%) (%)
      Lower improves ESG score
    • Board Independence (25-50%) (%)
      Lower improves ESG score
    • Board Independence (50-75%) (%)
      Higher improves ESG score
    • Board Independence (75-100%) (%)
      Higher improves ESG score
    Board Diversity
    • No Female Directors (%)
      Lower improves ESG score
    • Three OR More Female Directors (%)
      Higher improves ESG score
    • Females Represent 30% of Directors (%)
      Higher improves ESG score
    Entrenched Board
    • Entrenched Board (%)
      Lower improves ESG score
    Overboarding
    • Overboarding (%)
      Lower improves ESG score
    Shareholder Rights
    • Negative Director Votes (%)
      Lower improves ESG score
    • Ownership AND Control Flag (%)
      Lower improves ESG score
    • One Share One Vote (%)
      Lower improves ESG score
    • No Annual Director Elections (%)
      Lower improves ESG score
    • Does Not Use Majority Voting (%)
      Lower improves ESG score
    • Significant Votes Against Pay Practices (%)
      Lower improves ESG score
    Fund Ownership
    • Controlling Shareholder (%)
      Lower improves ESG score
    • Controlling Shareholder Concerns (%)
      Lower improves ESG score
    • Cross Shareholdings (%)
      Lower improves ESG score
    Poison Pill
    • Poison Pill (%)
      Lower improves ESG score
    Executive Compensation
    • Pay Flag (%)
      Lower improves ESG score
    • No Pay Performance Link (%)
      Lower improves ESG score
    • Lack of Internal Pay Equity (%)
      Lower improves ESG score
    • Executive Pay Non-Disclosure (%)
      Lower improves ESG score
    Accounting Flags
    • Accounting Flag (%)
      Lower improves ESG score

ARKG Performance

This section shows how this ETF has performed relative to its peers.

ARKG ETF Database
Category Average 		Factset Segment
Average
1 Month Return 3.25% 0.88% 2.13%
3 Month Return -27.66% -11.13% -18.94%
YTD Return -45.04% -18.66% -37.03%
1 Year Return -61.74% -20.12% -44.96%
3 Year Return 11.04% 14.47% 1.90%
5 Year Return 60.21% 25.28% 15.05%

Geographic Exposure

The following charts reflect the geographic spread of ARKG's underlying holdings.

Region Percentage
North, Central and South America 99.97%
Other 0.02%
Country Percentage
United States 92.95%
Switzerland 4.84%
Canada 1.57%
Israel 0.25%
Germany 0.23%
Other 0.14%
China 0.01%

Holdings Analysis

The following charts reflect the allocation of ARKG's underlying holdings.

Sector Percentage
Health Technology 68.86%
Technology Services 16.43%
Health Services 10.38%
Commercial Services 2.36%
Process Industries 1.82%
Miscellaneous 0.12%
Other 0.02%
Market Cap Percentage
Mid 42.85%
Small 32.55%
Micro 13.42%
Large 11.19%
Region Percentage
Asset Percentage
Share/Common/Ordinary 99.84%
Open-ended Fund 0.12%
Other 0.02%
American Depositary Receipt 0.01%
 
View Less Charts
 
Sector Percentage
Health Technology 68.86%
Technology Services 16.43%
Health Services 10.38%
Commercial Services 2.36%
Process Industries 1.82%
Miscellaneous 0.12%
Other 0.02%
 
View More Charts
 

ARKG Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETF Database Category.

5 Day Volatility 337.42%
20 Day Volatility 72.87%
50 Day Volatility 74.20%
200 Day Volatility 67.94%
Beta 1.58
Standard Deviation 19.54%
 
View Detailed Analysis
 
5 Day Volatility
337.42%
Rank
1 of 44
Low
BBC (17.35%)
High
ARKG (337.42%)
20 Day Volatility
72.87%
Rank
1 of 44
Low
PPH (20.23%)
High
ARKG (72.87%)
50 Day Volatility
74.20%
Rank
1 of 44
Low
PPH (20.06%)
High
ARKG (74.20%)
200 Day Volatility
67.94%
Rank
1 of 43
Low
PPH (18.72%)
High
ARKG (67.94%)
Beta
1.58
Rank
1 of 42
Low
BMED (-1.02)
High
ARKG (1.58)
Standard Deviation
19.54%
Rank
5 of 42
Low
FTXH (0.65%)
High
BBH (25.03%)

 
View Summary Analysis
 

Technicals

  • 20 Day MA $31.06
  • 60 Day MA $35.74
  • MACD 15 Period 2.94
  • MACD 100 Period -6.17
  • Williams % Range 10 Day 1.09
  • Williams % Range 20 Day 7.61
  • RSI 10 Day 61
  • RSI 20 Day 52
  • RSI 30 Day 48
  • Ultimate Oscillator 61

Bollinger Bands

  • Lower Bollinger (10 Day) $26.01
  • Upper Bollinger (10 Day) $33.37
  • Lower Bollinger (20 Day) $27.21
  • Upper Bollinger (20 Day) $34.80
  • Lower Bollinger (30 Day) $27.70
  • Upper Bollinger (30 Day) $34.57

Support & Resistance

  • Support Level 1 $31.97
  • Support Level 2 $30.27
  • Resistance Level 1 $34.55
  • Resistance Level 2 $35.43

Stochastic

  • Stochastic Oscillator %D (1 Day) 68.43
  • Stochastic Oscillator %D (5 Day) 77.21
  • Stochastic Oscillator %K (1 Day) 57.56
  • Stochastic Oscillator %K (5 Day) 59.55

Tradability

  • Tracking Difference Median (%) n/a
  • Tracking Difference Max Upside (%) n/a
  • Tracking Difference Max Downside (%) n/a
  • Median Premium Discount (%) -0.02
  • Maximum Premium Discount (%) 0.23
  • Average Spread (%) 1.40
  • Average Spread ($) 1.40

Financial Advisor Report

ETF Database's Financial Advisor Reports are designed as an easy handout for clients to explain the key information on a fund. Includes new analyst insights and classification data.

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETF Database. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Download the Fact Sheet PDF

Data Lineage

ETF Trends and ETF Database , the preeminent digital platforms for ETF news, research, tools, video, webcasts, native content channels, and more. The ETF Trends and ETF Database brands have been trusted amongst advisors, institutional investors, and individual investors for a combined 25 years. The firms are uniquely positioned to aid advisor’s education, adoption, and usage of ETFs, as well as the asset management community’s transition from traditionally analog to digital interactions with the advisor community.

Our team at ETF Database is committed to making our website the premier source of information on ETF investing with the world’s highest quality ETF tools, content, and resources.

Have Questions? Contact Us.

Powered By:

FactSet
Barchart

Analyst Report Authors

ETF Database analysts have a combined 50 years in the ETF and Financial markets, covering every asset class and investment style. The team monitors new filings, new launches and new issuers to make sure we place each new ETF in the appropriate context so Financial Advisors can construct high quality portfolios.

Disclosures

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2022 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.
Help & Info
Tools
More Tools
Explore ETFs
Legal